Viral hepatitis is inflammation of the liver caused by the five hepatotropic viruses A to E. A and E (usually) cause self-limited acute hepatitis; B, C and D can become chronic and lead to cirrhosis and hepatocellular carcinoma (HCC).
Key to diagnosis: jaundice with a very high ALT (alanine aminotransferase), then virus-specific serology: IgM anti-HAV, HBsAg with IgM anti-HBc, anti-HCV confirmed by HCV RNA, IgM anti-HEV with HEV RNA, anti-HDV in every HBsAg-positive patient. The INR measures severity.
Key to treatment: acute hepatitis is supportive; antivirals are for chronic infection: entecavir or tenofovir for hepatitis B, direct-acting antivirals (DAAs) that cure over 95% of hepatitis C, bulevirtide for hepatitis D, ribavirin for chronic hepatitis E. Epidemiology, vaccination and post-exposure prophylaxis: topics 11 (B, C) and 5 (A, E); HIV co-infection: topic 14.
Etiology
HEV genotypes 1 and 2 are waterborne (Asia, Africa); genotypes 3 and 4 are zoonotic (pork, wild boar and game) and are the ones seen in Europe, including Bulgaria.
Non-viral causes to remember: alcohol, drugs and toxins (paracetamol, amoxicillin-clavulanate), autoimmune hepatitis, Wilson disease, ischaemia; other viruses (EBV, CMV, HSV).